Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Oklahoma
Eli Lilly and Company
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Eli Lilly and Company
University of California, San Francisco
H. Lee Moffitt Cancer Center and Research Institute
Karolinska University Hospital